トレグ の 熱意 を 抑制 する
Taha Merghoub1, Jedd D Wolchok2
1Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Ludwig Institute for Cancer Research, New York, NY 10065, USA; Parker Institute for Cancer Immunotherapy, New York, NY 10065, USA.
Cell
|June 3, 2017
まとめ
ガンマインターフェロンを生成する調節性T細胞 (Tregs) は局所的に不安定化し,強力な抗腫瘍免疫を促進する. この発見は,がんの免疫療法の有効性を高める新しいメカニズムを明らかにしています.
科学分野:
- 免疫学
- 腫瘍学
- 細胞生物学
背景:
- 調節性T細胞 (Tregs) は免疫ホメオスタシスに不可欠ですが,腫瘍の微小環境内の抗腫瘍反応を抑制することができます.
- 癌におけるTregの可塑性と機能を理解することは,効果的な免疫療法を開発するために不可欠です.
研究 の 目的:
- 腫瘍の微小環境における特定のTregsのサブセットによるインターフェロンガンマ (IFN-γ) 生成の役割を調査する.
- IFN-γがTregの安定性および抗腫瘍免疫にどのように影響するかを決定する.
主な方法:
- 腫瘍の微小環境内のTreg集団とサイトカイン生成の分析.
- IFN-γに対するTregの安定性と機能の評価
- 抗腫瘍免疫反応への影響の評価
主要な成果:
- IFN-γの源として,腫瘍に浸透するTregsのサブセットが特定されました.
- これらのTregによるIFN-γの生成は,局所的なTregの不安定性を引き起こした.
- この不安定さは,抗腫瘍免疫活性が回復したとの関連があった.
結論:
- ガンマインターフェロンは,腫瘍の微小環境の中でTregの不安定性を引き起こす.
- このTreg調節は局所的な抗腫瘍免疫を強化し,潜在的な治療標的となる.
関連する概念動画
T Cell Types and Functions
2.9K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.9K
Feedback Inhibition
57.9K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.9K
Desensitization and Tachyphylaxis
3.3K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.3K
T Cell Activation and Clonal Selection
16.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.7K


